Abstract
BackgroundPulmonary involvement is one of the major causes of morbidity and mortality in patients with progressive systemic sclerosis (PSS). Clinically significant interstitial lung disease (ILD) is noted in 25% of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have